| Financial Year |
March 31 2023 |
| Monetary Funds |
1,414,113,624.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
26,769,020.58 |
| Accounts Receivable |
1,341,346,721.23 |
| Advances to Suppliers |
39,722,741.24 |
| Other Receivables |
79,939,783.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,137,412.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
187,194,390.79 |
| Total Current Assets |
3,363,521,423.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
248,183,889.55 |
| Investment Properties |
31,963,471.79 |
| Fixed Assetes |
1,858,747,743.03 |
| Under-construction Projects |
553,579,177.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
146,534,557.09 |
| R&D expenses |
-- |
| Goodwill |
759,210,431.32 |
| Long-Term Deferred and Prepaid Expenses |
127,374,983.10 |
| Deferred Income Tax Assets |
94,233,540.56 |
| Other Non-Current Assets |
118,451,674.45 |
| Sub-Total of Non-Current Assets |
4,289,174,917.02 |
| Total Assets |
7,652,696,340.19 |
| Short-Term Loans |
10,767,962.23 |
| Trading Financial liabilities |
1,900,000.00 |
| Notes Payable |
28,450.77 |
| Accounts Payable |
636,057,988.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
337,878,284.38 |
| Taxes Payable |
80,268,699.79 |
| Interest Payable |
-- |
| Dividend Payable |
351,042.91 |
| Other payables |
156,907,818.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,576,554.49 |
| Other Current Liabilities |
2,177,089.05 |
| Sub-Total of Current Liabilities |
1,442,796,151.04 |
| Long-term Loans |
10,167,352.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,213,111.94 |
| Deferred Income Tax Liabilities |
75,542,687.00 |
| Other Non-Current Liabilities |
556,302.56 |
| Sub-Total of Non-Current Liabilities |
408,788,170.64 |
| Total Liabilities |
1,851,584,321.68 |
| Paid-In Capital(Or Share Stock) |
1,682,828,214.00 |
| Capital Surplus |
428,428,588.32 |
| Surplus Reserve |
274,202,045.17 |
| LESS:Treasury Stock |
63,514,686.10 |
| Undistributed Profits |
3,254,201,837.55 |
| Minority Stockholder's Interest |
206,620,542.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,594,491,475.82 |
| Owner's Equity（Stockholder's Equity） |
5,801,112,018.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,652,696,340.19 |
